Professional Documents
Culture Documents
Penyakit Saluran Pernapasan
Penyakit Saluran Pernapasan
RESPIRATORY TRACT
INFECTION IN
CHILDREN
INTRODUCTION
RESPIRATORY TRACT
sinusitis
PATHOPHYSIOLOGY
•touching a hand exposed to pathogens to the nose or
mouth
•inhaling respiratory droplets from an infected person
BARRIERS
• Physical/mechanical
hair lining the nose, mucous,
ciliated cells production of
•Humoral immune defenses Ig A toxins,
•Cellular immune defenses proteases
macrophages, monocytes,
neutrophils & eosinophils
•Cytokines
(Phelan, 1994)
• MORTALITY
– One of the commonest cause of death in
children
– Cause around 3 million child deaths worldwide
each year:
• Most are caused by PNEUMONIA
• 99% occur in developing countries
(WHO, 1999)
35%
23%
6%
2% 2% 27%
5%
Pneumonia PNEUMONIA/MEASLES
MEASLES ARI/MEASLES
Malaria DIARRHOEA
OTHERS
• MORBIDITY
in children 5 years of age: 10-20%
(2.33 - 4.66 million)
• MORTALITY
>> PNEUMONIA
MORTALITY RATE IN 1992 :2.7/ 1000
(National Household Survey=SKRT,1992)
Malnutrition
In adequate
Inadequate breast feeding
immunization Vitamin A deficiency
Low birth
Young age weight
ARI
Pollution
Crowded
sinusitis
• AURI:
• common cold (rhinitis)
• pharyngitis-nasopharyngitis-tonsilopharyngitis
• sinusitis
• otitis media
• ALRI :
• epiglotitis
• laryngo-tracheobronchitis
• bronchitis
• bronchiolitis
• pneumonia
Common terms are defined as follows:
(Torres, 1997)
ETIOLOGY
• AURI : VIRUS ( 90%)
• COMMON VIRUSES
AURI : Rhinovirus, Coronavirus,
Adenovirus, Enterovirus
ALRI : RSV, Para influenza 1,2,3;
Coronavirus, Adenovirus,
Enterovirus
PNEUMONIA
Etiology of Community acquired
Penumonia (CAP) in hospitalized children
Fungal
•Histoplasma capsulatum
•Blastomises dermatitidis
Etiology in age of < 3 months
• Streptococcus group B
• Staphylococcus aureus
• Chlamyidia trachomatis
• Gram negative bacterials
Neonatus
• Related with labour process
- meconium aspiration
- mother’s leukorhoea
Etiology in age of 3 months - 5
years
Common
S. pneumoniae
H. influenzae
Rare
Streptococcus group
A
Etiology in age of > 5 years
Mycoplasma pneumoniae
Chlamydia pneumoniae
S. pneumoniae
H. influenzae
IN INDONESIA
• Etiology in 698 children with non severe pneumonia
• S. pneumoniae 67%
• Staphyloc.epidermidis 11.9%
• Alpha streptococcus 11.9%
• Hafnia alvei 3.4%
• Staphylococ.aureus 2.8%
• Moraxella catarhalis 1.1%
• Haemopphilus influenzae 0.6%
• Klebsiella pneumoniae 0.6%
Not specific
• Retraction/chest indrawing
• grunting
• Tachypneu
• Auscultation : not specific
Neonatus
difficult to differentiate from sepsis & meningitis
WHO/IMCI CLASSIFICATION
entry point: cough
the classification is based on respiratory
rate & chest indrawing
• 0 - 2 months of age
1. Severe pneumonia
2. No pneumonia
Sensitivity/spesificity
DYSPNEA
CHEST INDRAWING
INVESTIGATION
Pulse oxymetry should be performed in
every children with pneumonia
Chest X-ray
should not be performed routinely in mild uncomplicated LRI
The findings are poor indicators of etiology
INVESTIGATION
Blood culture
Nasopharyngeal aspirates
From all children under the age of 18 months should be sent for viral antigen
detection
• Antypiretics
Antibiotic Management
• Young children with mild symptoms need not be
treated with antibiotics
• Children under the age of 5 years:
the first choice for oral antibiotic : amoxycillin
alternatives: co-amoxiclav, cefaclor, erythromycin,
clarithromycin & azithromycin.
• Etiological agents
• Rhinovirus 30 – 40%
• Influenza 10-15%
• Coronavirus > 10%
• RSV 5-10%
• Parainfluenza 5-10%
• Adenovirus 5%
• Enterovirus < 5%
• Mycoplasma < 5%
Common cold – does it need
antibiotics?
• Uncomplicated common cold NO
• Evidence of acute otitis media YES
• Nasal discharge show no improvement in 10
days may consider antibiotics (after
excluding foreign body)
• Antibiotics
• Target: pneumococci, Hib, GAS, anaerobic
• amoxicillin, 1st/2nd cephalosporin, amox-calvulanic acid
Pharyngitis
• Etiology:
• Virus: rhinovirus, coronavirus, adenovirus, HSV,
parainfluenza, influenza
• Standard treatment
• Penicillin V for 10 days
• Alternate treatment
• Macrolides (higher chance of resistence)
• 1st generation cephalosporin
Thank you